Study to Investigate the Efficacy of Elbasvir/Grazoprevir Fixed-Dose Combination for 8 Weeks in Treatment-Naïve, HCV GT1b-Infected Patients, With Non-severe Fibrosis
Clinical trial NCT02973503 · COMPLETED
Trial details
- NCT number
- NCT02973503
- Sponsor
- University Hospital, Clermont-Ferrand
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-01-11
- Primary completion
- 2018-11-10
- Enrollment
- 117
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.